Teri Loxam sold $669K of Vaxcyte (PCVX)

Executed Sep 17 2024, disclosed Sep 18 2024, 1 day later.

Value, as filed

$669K

5,753 sh across 2 lots

Executed

Sep 17 2024

the trade date, as filed

Disclosed

Sep 18 2024

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Teri Loxam Director profile →

Teri Loxam (Director) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Vaxcyte, Inc. (PCVX). The largest single filing was $101K of PCVX (1,202 sh × $83.93, as filed), executed Jan 15 2025.

The name

PCVX

Vaxcyte, Inc. PCVX · Healthcare · 41 filings in 24 months ticker →

Healthcare · Vaxcyte, Inc., a clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial inf…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Teri Loxam in PCVX

PCVXSALE Vaxcyte, Inc. $101K
1,202 sh × $83.93
Exec Jan 15 2025
Filed Jan 17 2025 · 5:30 PM ET